Home » Topics » Regulatory

Regulatory
RSS

Vaqta gets the green light from FDA

April 12, 1996

Improved Havrix approved by FDA

April 12, 1996

Carbonic anhydrase inhibitor tested for parkinsonism

April 12, 1996

Genentech files for new indication for alteplase

April 5, 1996

Nasacort effective in hay fever sufferers

March 15, 1996

Pharmos completes loteprednol etabonate trial

March 15, 1996

FDA approves expanded labeling for Ethyol

March 15, 1996

Aminopterin resurrected for ALL

March 15, 1996

Neupogen approved for AIDS-related indication

March 15, 1996

FDA approves HIV drug

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...